Cite

HARVARD Citation

    Graveno, M. et al. (2022). Venetoclax in combination with hypomethylating agents or low dose cytarabine for relapsed and refractory acute myeloid leukemia. Leukemia & lymphoma. 63 (7), pp. 1645-1650. [Online]. 
  
Back to record